Milk haptoglobin, milk amyloid A, and N-acetyl-β-d-glucosaminidase activity in bovines with naturally occurring clinical mastitis diagnosed with a quantitative PCR test  by Kalmus, P. et al.
3662
J. Dairy Sci.  96 :3662–3670
http://dx.doi.org/ 10.3168/jds.2012-6177 
© American Dairy Science Association®,  2013 .
 ABSTRACT 
 The associations between quantitative bacteriological 
results from a real-time PCR test and concentrations 
of acute-phase proteins (APP) and N-acetyl-β-d-
glucosaminidase (NAGase) activity in milk in naturally 
occurring clinical mastitis were investigated. Milk APP 
concentrations and NAGase activity in clinical mastitis 
caused by different udder pathogens were studied. The 
associations between the severity of the clinical signs 
and concentrations of APP and NAGase activity were 
estimated. Milk samples from 281 cases of clinical mas-
titis were collected from 3 Estonian dairy farms and 
analyzed by PCR to identify pathogens. Twenty-seven 
samples out of 281 (9.6%) were PCR negative. Milk 
samples containing 4 or more bacterial species (n = 
28) were considered possibly contaminated and ex-
cluded from all further analyses. In total, 443 bacterial 
identifications were made from the remaining 226 milk 
samples. A single bacterial species was detected in 68 
samples (30.1%), 2 species were detected in 99 samples 
(43.8%), and 3 species were detected in 59 (26.1%) 
samples. To determine the inflammatory response 
in the udder, the concentrations of milk amyloid A 
(MAA) and haptoglobin (Hp) and NAGase activity in 
the milk were analyzed. A significant positive associa-
tion was found between the severity of the clinical signs 
and inflammatory markers in the milk. Milk amyloid 
A and Hp concentrations and NAGase activity were 
significantly higher in samples with large quantities of 
bacterial DNA from Escherichia coli or Streptococcus 
dysgalactiae compared with milk samples not containing 
those species. Large quantities of bacterial DNA from 
Trueperella pyogenes or Streptococcus uberis in the milk 
were associated with elevated concentrations of Hp and 
high NAGase activity, but not with increased MAA 
concentrations. Milk samples containing Corynebacte-
rium bovis and coagulase-negative staphylococci had 
significantly lower concentrations of MAA and Hp and 
lower NAGase activity compared with samples where 
these species were not detected. It can be concluded 
that concentrations of APP and NAGase activity in 
the milk were associated with the quantity of bacterial 
DNA in the milk samples. 
 Key words:   clinical mastitis ,  acute-phase protein , 
N-acetyl-β-d-glucosaminidase (NAGase) activity ,  real-
time PCR 
 INTRODUCTION 
 Knowledge of the causative pathogens is required for 
appropriate control and treatment of mastitis. Bacte-
rial culture has been the gold standard for mastitis 
diagnostics (NMC, 2004), but a commercial PCR-based 
method has been introduced as a routine method for 
detection of mastitis-causing bacteria (PathoProof 
Mastitis PCR Assay; Thermo Fisher Scientific, Espoo, 
Finland). Due to the greater sensitivity of the PCR 
test compared with the conventional methods, often 
resulting in detection of more species per sample, the 
interpretation of the PCR results is challenging (Koski-
nen et al., 2010). More research concerning the use and 
interpretation of PCR mastitis tests in routine use is 
warranted. 
 Mastitis-causing bacteria entering the udder quarter 
via the teat canal, establish IMI with varying degrees 
of tissue injury. Tissue injury and inflammation initiate 
an acute-phase response (APR), which most commonly 
begins by releasing inflammatory mediators from tissue 
macrophages or blood monocytes that gather at the site 
of damage (Baumann and Gauldie, 1994; Koj, 1996). 
An APR results in an increase in systemic and local 
concentrations of acute-phase proteins (APP). Two of 
those proteins, haptoglobin (Hp) and serum amyloid 
A, play a significant role in the early response of the 
mammary gland to pathogenic bacteria (Eckersall et 
al., 2001; Nielsen et al., 2004). Haptoglobin is diffused 
from blood into the milk, but also originates from milk 
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leukocytes and epithelial cells in the mammary gland 
(Hiss et al., 2004). Serum amyloid A is secreted by 
hepatocytes and, in addition, the mammary gland epi-
thelium appears to secrete a mammary gland-specific 
isoform mammary-associated serum amyloid A 3 (M-
SAA3) milk amyloid A (MAA; Eckersall et al., 2001).
Local APR in the udder have mostly been studied us-
ing experimental models in which pathogenic bacteria 
such as Escherichia coli (Hyvönen et al., 2006; Suojala 
et al., 2008; Larsen et al., 2010) or staphylococci (Grön-
lund et al., 2003; Simojoki et al., 2009) have been in-
fused into the udder quarter. These studies showed that 
E. coli increases concentrations of APP in the milk to 
a greater extent than CNS or Staphylococcus aureus. A 
field study by Pyörälä et al. (2011) concluded that the 
concentrations of Hp and MAA in milk vary depending 
on which pathogens are isolated. Concentrations of APP 
were the highest in cases where mastitis was caused 
by E. coli and significantly lower when mastitis was 
caused by streptococci or Staph. aureus. Milk amyloid 
A and Hp inflammatory responses were very mild in 
mastitis caused by CNS. N-Acetyl-β-d-glucosaminidase 
(NAGase) is an intracellular, lysosomal enzyme that 
is released into milk from neutrophils during phagocy-
tosis and cell lysis, but also from damaged epithelial 
cells, indicating udder tissue destruction (Kitchen et 
al., 1984). Milk NAGase activity correlates very closely 
with SCC and can be analyzed also from frozen milk 
samples (Kitchen et al., 1984).
The first objective of the study was to investigate 
associations between different quantities of bacterial 
DNA detected using a PCR-based method and con-
centrations of APP and NAGase activity in milk from 
bovines with naturally occurring clinical mastitis. The 
second aim was to compare milk APP concentrations 
and NAGase activity in clinical mastitis caused by dif-
ferent udder pathogens and to study the effect of the 
severity of clinical signs.
MATERIALS AND METHODS
Milk Samples and Clinical Examination
Milk samples from cows diagnosed with clinical mas-
titis were collected for a treatment study, which was 
conducted during the period 2007 to 2009 in Estonia. 
Milk samples originated from 3 different loose-housing 
dairy farms. Herd sizes ranged from 300 to 1,000 cows. 
Among those herds, annual mean milk production was 
8,500 to 9,800 kg, and the average bulk milk SCC was 
between 180,000 and 450,000 cells/mL. All herds were 
milked 3 times per day. Clinical mastitis was diagnosed 
by trained farm personnel at milking time. Clinical 
mastitis was defined according to the International 
Dairy Federation (IDF, 1999), which specifies that at 
least some visible signs should be present in the udder 
or in the milk. Systemic and local signs were recorded 
and categorized on a 3-point scale as follows: (1) mild 
clinical mastitis: milk from a quarter had abnormal 
viscosity (watery or thicker than normal), color (yel-
low or blood-tinged), or consistency (flakes or clots), 
but no udder swelling or systemic signs; (2) moderate 
clinical mastitis: similar to mild clinical mastitis, but 
with the addition of visible or palpable changes in the 
udder (swelling or pain) without systemic signs; and (3) 
severe clinical mastitis: both local and systemic signs 
(fever above 39.2°C). All cow data (affected quarter, 
score of clinical mastitis, age, and DIM) were recorded.
Once clinical mastitis was diagnosed, a milk sample 
from the diseased udder quarter was collected for bac-
teriological examination. Before collection, the teat end 
was cleaned with 70% ethanol swabs and allowed to 
dry. After discarding a few streams of milk, samples (2 
to 4 mL) were collected into sterile 10-mL plastic tubes 
and frozen at −20°C until further investigation. Only 1 
diagnosed case of clinical mastitis per cow was included 
in the study.
During the study period, milk samples were collected 
from 35 cows at farm 1, 123 cows at farm 2, and 105 
cows at farm 3; a total of 281 quarter milk samples 
from 263 cows were included. Eighteen cows had 2 af-
fected quarters.
Real-Time PCR Assay
A commercial real-time PCR test kit (PathoProof 
Mastitis PCR Assay; Thermo Fisher Scientific) was 
used for direct analysis of all milk samples. The kit pro-
tocol involved 4 separate multiplex real-time PCR reac-
tions, which targeted 11 bacterial species and groups 
(covering more than 25 mastitis-causing species in to-
tal): Staphylococcus spp. (including Staph. aureus and 
all relevant CNS species), Enterococcus spp. (including 
Enterococcus faecalis and Enterococcus faecium), Cory-
nebacterium bovis, E. coli, Streptococcus dysgalactiae, 
Streptococcus agalactiae, Streptococcus uberis, Trueper-
ella (formerly Arcanobacterium) pyogenes/Peptoniphilus 
indolicus (Yassin et al., 2011), Klebsiella spp. (including 
Klebsiella oxytoca and Klebsiella pneumoniae), and Ser-
ratia marcescens. The testing was done according to the 
user’s manual and described by Koskinen et al. (2010). 
Based on the cycle threshold (Ct) values, the bacterial 
DNA quantity in each targeted bacterial species was 
grouped into 3 classes: small quantity (+), intermediate 
quantity (++), or large quantity (+++), according to 
the manufacturer’s manual.
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Analytical Methods for Determination  
of Inflammatory Response in Milk
The concentration of MAA in milk was determined 
using a commercial ELISA kit (Phase MAA Assay Kit; 
Tridelta Development Ltd., Maynooth, Co. Kildare, 
Ireland). Milk samples were initially diluted to 1:500. 
If the concentration was above the range of a stan-
dard curve, they were further diluted as necessary. For 
very high MAA values, milk samples were diluted up 
to 1:10,000 (maximum concentration 1,500 mg/L). A 
1:100 dilution was used (minimum concentration 0.94 
mg/L) for very low values. Intra- and interassay coef-
ficients of variation were <13 and <12%, respectively.
Milk Hp concentrations (mg/L) were determined 
by a method based on the ability of Hp to bind to 
hemoglobin (Makimura and Suzuki, 1982) and using 
tetramethylbenzidine as a substrate (Alsemgeest et al., 
1994). The assay is meant to determine concentrations 
of Hp in the serum, but was adapted here to be used 
for milk, as described by Hyvönen et al. (2006). Opti-
cal densities of the formed complex were measured at 
450 nm using a spectrophotometer. Lyophilized bovine 
acute-phase serum was used as a standard, and calibra-
tion was carried out according to the European Union 
concerted action on the standardization of animal APP 
(number QLK5-CT-1999-0153). The working range of 
the assay was 60 to 1,900 mg/L. The interassay and 
intraassay coefficient of variation values for Hp analysis 
were <8 and <13%, respectively.
Milk NAGase Activity Determination
Milk NAGase activity was measured by a fluoro-op-
tical method using an in-house microplate modification 
developed by Mattila and Sandholm (1985) and further 
modified by Hovinen et al. (2010). The calibrated milk 
sample was replaced with a control milk sample with 
a known 4-methyl-umbelliferon (4-MU) concentration, 
and NAGase activity was expressed as picomoles of 
4-MU/min per microliter of milk at 25°C. The upper 
detection limit for NAGase activity was 24.5 pmol of 
4-MU/min per microliter. Interassay and intraassay 
coefficients of variation for NAGase activity were 5 and 
4%, respectively.
Statistical Analysis
Stata 10.0 (StataCorp, TX) software was used for 
statistical analyses. Only milk samples with PCR-
negative results or ≤3 pathogen species were analyzed 
(n = 253). Generalized linear mixed models (GLMM) 
were used to investigate associations between milk APP 
and PCR results. The outcome variable MAA was loga-
rithmically transformed, and the inverse square root 
transformation of Hp was used. As Hp is evaluated us-
ing a model in inverse scale, negative model estimates 
represent higher Hp concentrations. The full models 
included lactation number as a 4-level categorical vari-
able (1, 2, 3, and ≥4 lactations), DIM was categorized 
as a 4-level variable according to quartiles (1–19, 20–59, 
60–118, and 119–412 DIM), farm as a 3-level variable, 
and affected quarter as a 2-level variable (fore and hind 
quarters). These variables were kept in all models to 
control possible confounding effects. As these variables 
were not significant in any of the models (except af-
fected quarters in the MAA model), they are not shown 
in our results. The PCR results by pathogen were in-
cluded as categorical variables (negative, +, ++, or 
+++). If PCR results were under 6 cases per level, 
they were consolidated with the previous factor level 
as follows: C. bovis ++ with C. bovis +; Strep. aga-
lactiae +++ with Strep. agalactiae ++; Strep. dysga-
lactiae +++ with Strep. dysgalactiae ++; T. pyogenes 
+++ with T. pyogenes ++; and CNS +++ with CNS 
++. To account for clustering of data (13 cows had 2 
samples from different quarters), cow was included as 
random factor. The Wald test was used to evaluate 
the overall significance of the categorical variables with 
more than 2 levels. Nonsignificant PCR result variables 
were removed using the stepwise backward elimination 
procedure. Both final models were tested for interac-
tions between minor pathogens (C. bovis and CNS) and 
major pathogens (E. coli, T. pyogenes, Strep. uberis, 
and Strep. dysgalactiae).
The random effects Tobit regression model for cen-
sored data was used to investigate associations between 
milk NAGase activity and PCR results. The Tobit re-
gression model was chosen because >40% of the NAGase 
results were over the maximum working limit of the 
assay (24.5 pmol of 4-MU/min per microliter), which 
would violate the regression model’s assumptions. In 
the Tobit regression, all cases falling above (or below) 
a specified threshold value are censored, although these 
cases remain in the analysis (Long, 1997). A more de-
tailed explanation using Tobit regression for analyzing 
milk NAGase activity data are given in Pyörälä et al. 
(2011). Square root transformation of milk NAGase ac-
tivities was used to achieve a normal distribution of un-
censored data; 104 samples were censored at the level of 
24.5 pmol of 4-MU/min per microliter. All other model 
building strategies and variables in each model were as 
described for the APP models above.
A linear regression model for APP and a Tobit re-
gression model for NAGase were used to investigate 
the associations of milk APP concentrations and milk 
NAGase activities with the severity of clinical mastitis 
(mild, moderate, and severe signs). Assumptions of all 
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models were controlled using normality and scatter 
plots of model residuals.
RESULTS
Bacteriological Findings
Ten different species of udder pathogens were detect-
ed in the 281 quarter milk samples using the real-time 
PCR kit. A total of 27 milk samples (9.6%) were PCR 
negative, and 254 (90.4%) samples contained DNA of 
at least 1 target species. Milk samples containing DNA 
of 4 or more bacterial species (n = 28) were considered 
possibly contaminated and excluded from further anal-
ysis. In total, 443 bacterial identifications were made 
from the remaining 226 milk samples. A single bacterial 
species was found in 68 (30.1%), 2 species were found 
in 99 (40.8%), and 3 species were found in 59 (26.1%) 
of the DNA-positive milk samples.
The most prevalent bacterial species among the milk 
samples containing a single pathogen were Strep. uberis 
(n = 20; 29.4%), Staph. aureus (n = 14; 20.5%), and E. 
coli (n = 13; 19.1%). Streptococcus uberis was detected 
in 45 (45.4%) and CNS was detected in 40 (40.4%) of 
the milk samples with 2 bacterial species.
Different quantities and proportions of mastitis-caus-
ing bacteria were detected in the milk samples (Table 
1). None of the milk samples contained 2 or 3 bacterial 
species in large quantities simultaneously. Of the 98 
milk samples containing DNA from CNS, the quantity 
was small (+) in 78 of them (85.7%). Bacterial DNA 
from Enterococcus spp. and Klebsiella spp. was detected 
rarely and only in small quantities.
Clinical Signs, APP, and NAGase Activity in Milk
In a total of 253 analyzed mastitis cases, 63.6% (n 
= 161) exhibited mild clinical signs and 31.2% (n = 
79) moderate clinical signs. Severe clinical signs were 
recorded in 5.1% (n = 13) of the cases. All samples 
collected from cows with severe mastitis were positive 
for bacteria, and E. coli was detected in 10 of the 13 
samples. Streptococcus uberis and CNS were the main 
bacterial species in moderate and mild clinical masti-
tis. Clinical signs in the cows yielding PCR-negative 
samples were moderate or mild.
The concentration of MAA in milk ranged between 
0.94 and 1,500 mg/L [median: 43.3 mg/L; interquartile 
range (IQR): 16.9–183.3 mg/L], and Hp varied from 59 
to 1,890 mg/L (median: 214.1 mg/L; IQR: 105.7–398.6). 
Of the 253 milk samples, 2 samples contained an MAA 
concentration below the working limits of the assay, and 
13 samples contained an MAA concentration above the 
working limits of the assay (0.94 and 1,500 mg/L, re-
spectively). Twenty-one samples had Hp concentrations 
under the working limit of the assay (59 mg/L). The 
activity of NAGase in milk ranged between 0.53 and 
24.5 pmol of 4-MU/min per microliter (median: 19.5 
pmol of 4-MU/min per microliter; IQR: 7.9–24.5 pmol 
of 4-MU/min per microliter), and in 104 milk samples, 
the NAGase activity was above the working range of 
the assay (24.5 pmol of 4-MU/min per microliter).
An association between the severity of clinical signs 
and the concentrations of APP and NAGase activity 
in the milk was found. In cases of severe clinical masti-
tis, MAA and Hp concentrations and NAGase activity 
values were significantly higher compared with cases 
of clinical mastitis with mild or moderate signs (P < 
0.001, P = 0.006, and P = 0.021, respectively). Con-
centrations of MAA and Hp and NAGase activity in 
milk from cows with moderate clinical mastitis were 
significantly higher than values measured in milk from 
cows with mild clinical signs (P < 0.001, P = 0.007, 
and P < 0.001, respectively).
Descriptive statistics of APP concentrations and 
NAGase activities in milk samples from clinical mas-
Table 1. Bacterial DNA quantities of udder pathogens detected in 226 milk samples from cases of cows with naturally occurring clinical mastitis1 
Identified mastitis pathogen (n = 443)
% of all DNA-positive 
milk samples 
(n = 226)
No. (%); mean Ct value2
+ ++ +++ 
Staphylococcus aureus (n = 49) 21.6 12 (24.4); 33.9 19 (38.7); 27.1 18 (36.7); 21.9
CNS (n = 91) 40.2 78 (85.7); 34.6 12 (13.1); 28.3 1 (1.1); 19.3
Streptococcus agalactiae (n = 12) 5.3 2 (16.6); 26.3 6 (50.0); 29.4 4 (33.3); 17.1
Streptococcus dysgalactiae (n = 33) 14.6 14 (42.4); 34.1 17 (51.5); 25.7 2 (6.1); 16.3
Streptococcus uberis (n = 98) 43.3 33 (33.6); 35.0 29 (29.6); 27.3 36 (36.7); 18.1
Trueperella pyogenes (n = 34) 15.0 24 (70.5); 35.1 5 (14.7); 25.1 5 (14.7); 19.4
Corynebacterium bovis (n = 53) 23.4 50 (94.3); 33.7 3 (5.7); 24.6 0
Enterococcus spp. (n = 4) 1.7 4 (100); 35.6 0 0
Escherichia coli (n = 67) 29.6 19 (28.3); 35.6 30 (44.8); 30.2 18 (26.8); 18.5
Klebsiella spp. (n = 2) 0.9 2 (100); 32.5 0 0
1+ = small quantities of bacterial DNA [range of cycle threshold (Ct) values: 28.3–37]; ++ = intermediate quantities of bacterial DNA (range 
of Ct values: 22.1–33.7); +++ = large quantities of bacterial DNA (range of Ct values: 13.4–27.4).
2Cycle threshold values of each pathogen were based on the quantity of bacterial DNA.
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titis is presented in Table 2. Associations between the 
concentrations of APP and NAGase activities in the 
milk and the PCR results are presented in Tables 3, 4, 
and 5. Concentrations of Hp and MAA and NAGase 
activity in the milk were not affected by farm, lactation 
number, or DIM (P > 0.05; data not shown). The af-
fected quarter (fore or hind) did not affect the Hp con-
centrations or the NAGase activities in milk (P > 0.05; 
data not shown). Significantly higher concentrations of 
MAA were found in the hind quarters compared with 
the fore quarters (Table 3).
Haptoglobin and MAA concentrations and NAGase 
activity in the milk were significantly higher when E. 
coli ++ and +++ or Strep. dysgalactiae ++/+++ were 
detected, compared with all other milk samples where 
these species were not detected. In addition, a small 
quantity (+) of E. coli in milk samples was associated 
with an elevated NAGase activity and MAA concentra-
tion. The presence of T. pyogenes at high levels in milk 
samples caused a significant elevation in Hp concentra-
tion, as well as an increased NAGase activity in the 
milk (P < 0.001 and P < 0.001, respectively) compared 
with milk samples without T. pyogenes. However, no 
association between the MAA concentration and the 
presence of T. pyogenes was found (P > 0.05; data not 
shown). Milk samples containing DNA from C. bovis or 
Table 2. Concentrations of milk amyloid A (MAA), haptoglobin (Hp), and N-acetyl-β-d-glucosaminidase (NAGase) activity in milk samples 
from cows with clinical mastitis (n = 147)1 
Pathogen
Median (minimum; maximum) value
MAA (mg/L) Hp (mg/L)
NAGase activity  
(pmol of 4-MU/min  
per microliter)2
Staphylococcus aureus (n = 18) 35.8 (6.7; 1,500) 201.1 (59.0; 756.2) 22.5 (2.7; 24.5)
CNS3 (n = 11) 29.2 (8.5; 1,500) 123 (59.0; 775.5) 11.86 (6.6; 24.5)
Streptococcus agalactiae (n = 4) 53.5 (28.9; 735.7) 295.5 (172.1; 506.1) 20.6 (6.6; 24.5)
Streptococcus dysgalactiae (n = 19) 147.6 (7.2; 905.2) 248.9 (74.8; 1,118.2) 20.8 (3.28; 24.5)
Streptococcus uberis (n = 36) 53.1 (4.5; 1,500) 385.6 (59.0; 970.3) 24.5 (3.36; 24.5)
Trueperella pyogenes (n = 10) 25.6 (0.95; 348.9) 618.5 (5.0; 1,155.8) 24.5 (1.73; 24.5)
Corynebacterium bovis4 (n = 4) 12.4 (0.09; 107.3) 95.8 (59.0; 108.6) 9.9 (0.5; 14.7)
Escherichia coli (n = 18) 394.1 (1.75; 1,500) 575.4 (59.0; 1,288.1) 24.5 (2.5; 24.5)
PCR negative (n = 27) 23.2 (7.4; 152.2) 164.1 (59.0; 548.3) 9.2 (1.3; 24.5)
1Only milk samples with 1 bacterial species only or 1 bacterial species in large quantity (+++) are included in the table.
24-MU = 4-methyl-umbelliferon.
3Milk samples where only bacterial DNA of small/intermediate quantity (+/++) of CNS was detected.
4Milk samples where only bacterial DNA of C. bovis +/++ was detected.
Table 3. Final generalized linear mixed model (GLMM) of associations between the concentration of milk amyloid A (MAA) in the milk and 
the pathogens detected with PCR (n = 253) from cows with naturally occurring clinical mastitis 
Variable1 Estimate2 95% CI P-value
Wald test  
(P-value)
Quarter
 Fore quarters (n = 102) 0
 Hind quarters (n = 179) 0.539 0.176; 1.011 0.005
Escherichia coli <0.001
 E. coli negative3 (n = 186) 0
 + (n = 19) 0.857 0.104; 1.610 0.026
 ++ (n = 30) 0.636 −0.025; 1.299 0.059
 +++ (n = 18) 1.68 0.843; 2.525 0.000
Streptococcus dysgalactiae 0.001
 Strep. dysgalactiae negative (n = 220) 0
 + (n = 14) 0.124 −0.737; 0.985 0.788
 ++/+++ (n = 19) 1.386 0.635; 2.136 0.000
Corynebacterium bovis
 C. bovis negative (n = 200) 0
 +/++ (n = 53) −0.664 −1.151; −0.140 0.012
Intercept 3.116 2.192; 4.040 0.000
1+ = small quantities of bacterial DNA; ++ = intermediate quantities of bacterial DNA; +++ = large quantities of bacterial DNA.
2Estimates are on a logarithmic scale.
3Number of milk samples not containing DNA from detected bacteria.
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a small quantity of DNA from CNS had a significantly 
lower concentration of APP and lower NAGase activity 
compared with all other milk samples where other spe-
cies were detected.
No interaction was detected in the models between 
minor (C. bovis and CNS) and major (E. coli, Strep. 
dysgalactiae, T. pyogenes, and Strep. uberis) pathogens. 
This means that any association between major patho-
gen DNA and the concentrations of the inflammatory 
markers was not influenced by the presence of minor 
pathogen DNA in the milk samples.
DISCUSSION
This study describes the associations between con-
centrations of APP in the milk and PCR-based bac-
teriological findings in cases of clinical mastitis. The 
amount of bacterial DNA detected in the samples from 
mastitis caused by certain species was associated with 
MAA and Hp concentrations and NAGase activity in 
the milk. The highest concentrations of MAA and the 
highest NAGase activities in milk were found in cows 
with large quantities of E. coli in their milk. This is in 
accordance with experimental studies showing a strong 
inflammatory response to E. coli (Hyvönen et al., 2006; 
Suojala et al., 2008). Wenz et al. (2010) found that the 
concentration of Hp was the highest in E. coli-induced 
mastitis compared with mastitis caused by environmen-
tal streptococci or CNS. However, even small quantities 
of E. coli resulted in elevated concentrations of MAA 
and increased NAGase activity in the milk. Experimen-
tal studies have shown that even a small quantity of 
E. coli can induce an acute inflammatory reaction in 
the udder (Frost et al., 1982). Escherichia coli bacteria 
are generally eliminated rapidly from the udder, but 
trigger a strong inflammatory reaction, which is mainly 
due to endotoxin (Burvenich et al., 2003). In practice, 
the time of sampling after the onset of clinical mastitis 
could also influence the quantity of DNA of E. coli in 
the milk. Sampling late during the course of infection 
could explain the small quantity of E. coli detected in 
bacteriological examination, despite a strong inflamma-
tory response.
Our findings support the results reported by Pyörälä 
et al. (2011), who found that higher concentrations of 
Hp and NAGase corresponded to the detection of T. 
pyogenes in mastitic milk samples but could establish 
no association between T. pyogenes and MAA. This 
could indicate that IMI due to T. pyogenes does not 
induce significant local production of MAA. Release of 
Table 4. Final generalized linear mixed model (GLMM) of associations between concentration of haptoglobin (Hp) in the milk and the 
pathogens detected with PCR (n = 253) from cows with naturally occurring clinical mastitis 
Variable1 Estimate2 95% CI P-value
Wald test  
(P-value)
Trueperella pyogenes <0.001
 T. pyogenes negative3 (n = 219) 0
 + (n = 24) −0.005 −0.017; 0.007 0.415
 ++/+++ (n = 10) −0.037 −0.055; −0.019 0.000
Escherichia coli <0.001
 E. coli negative (n = 186) 0
 + (n = 19) −0.004 −0.018; 0.009 0.532
 ++ (n = 30) −0.021 −0.033; −0.008 0.001
 +++ (n = 18) −0.029 −0.047; −0.014 0.000
Streptococcus uberis <0.001
 Strep. uberis negative (n = 164) 0
 + (n = 33) 0.002 −0.009; 0.012 0.784
 ++ (n = 29) −0.009 −0.021; 0.003 0.150
 +++ (n = 36) −0.023 −0.034; −0.012 0.000
Streptococcus dysgalactiae 0.008
 Strep. dysgalactiae negative (n = 220) 0
 + (n = 14) 0.006 −0.010; 0.021 0.465
 ++/+++ (n = 19) −0.020 −0.034; −0.007 0.003
CNS 0.10
 CNS negative (n = 162) 0
 + (n = 78) 0.008 0.0003; 0.016 0.040
 ++/+++ (n = 13) 0.008 −0.009; 0.024 0.358
Corynebacterium bovis
 C. bovis negative (n = 200) 0
 +/++ (n = 53) 0.013 0.005; 0.023 0.002
Intercept 0.089 0.072; 0.107 0.000
1+ = small quantities of bacterial DNA; ++ = intermediate quantities of bacterial DNA; +++ = large quantities of bacterial DNA.
2Estimates are on an inverse square root scale (negative estimate means higher concentration of Hp).
3Number of milk samples not containing DNA from detected bacteria.
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different APP may depend on the pathogens present. 
The major producers of Hp and NAGase in milk are 
neutrophils and epithelial cells, whereas only mammary 
gland epithelial cells appear to secrete MAA in cows 
with mastitis (Kitchen et al., 1984; Eckersall et al., 
2006; Lai et al., 2009). Epithelial damage may manifest 
differently in different infections, which in turn could 
affect MAA concentrations in the milk.
The presence of Staph. aureus in the udder increased 
the concentrations of APP and the NAGase activity 
in the milk less than other major pathogens, indicat-
ing a mild inflammatory response in this infection. In 
experimentally induced Staph. aureus mastitis, the con-
centrations of Hp and MAA ranged between 52 and 323 
mg/dL and between 34 and 286 mg/dL, respectively 
(Grönlund et al., 2003), and were lower than those 
found in experimentally induced Strep. uberis or E. coli 
mastitis (Pedersen et al., 2003; Suojala et al., 2008). 
Concentrations of Hp and MAA and NAGase activity 
in naturally acquired Staph. aureus mastitis were also 
lower than in streptococcal or E. coli mastitis (Pyörälä 
et al., 2011). In the present study, mastitis caused by 
Staph. aureus may have been very mild, which could 
explain the weak inflammatory response detected in 
the udder quarters. A small quantity of Staph. aureus 
DNA in the milk samples could also indicate that the 
bacteria were just skin contaminants and not the actual 
cause of the mastitis (Haveri et al., 2008).
In the present study, CNS and C. bovis were common 
bacterial species detected, mainly in small quantities, 
in milk samples positive for several species. C. bovis 
and CNS were the main pathogens detected using 
PCR from milk samples without growth (Taponen et 
al., 2009) and in the study by Koskinen et al. (2010) 
comparing conventional bacterial culturing and PCR 
in mastitis milk diagnostics. The frequent detection 
of these bacteria may be due to their extramammary 
origin. Corynebacterium bovis and CNS are generally 
considered to be opportunistic bacteria inhabiting teat 
skin and canals (Taponen et al., 2008). Nevertheless, 
the presence of CNS and C. bovis in the milk samples 
alone could increase concentrations of APP and NA-
Gase activity in the milk, indicating that these bacteria 
are able to invade the udder and induce an inflamma-
tory reaction. The PCR method allows the quantitative 
detection of udder pathogens and is especially useful 
Table 5. Random effects Tobit regression model of associations between N-acetyl-β-d-glucosaminidase (NAGase) activity in the milk and the 
pathogens detected with PCR (n = 253) from cows with naturally occurring clinical mastitis 
Variable1 Estimate2 95% CI P-value
Wald test  
(P-value)
Trueperella pyogenes 0.006
 T. pyogenes negative3 (n = 219) 0
 + (n = 24) 0.041 −0.721; 0.804 0.91
 ++/+++ (n = 10) 2.173 0.847; 3.499 0.001
Escherichia coli 0.002
 E. coli negative (n = 186) 0
 + (n = 19) 0.806 −0.025; 1.638 0.057
 ++ (n = 30) 1.247 0.486; 2.007 0.001
 +++ (n = 18) 1.464 0.500; 2.428 0.003
Streptococcus uberis <0.001
 Strep. uberis negative (n = 164) 0
 + (n = 18) −0.276 −0.934; 0.382 0.41
 ++ (n = 17) 0.159 −0.544; 0.861 0.66
 +++ (n = 30) 2.416 1.555; 3.276 0.000
Streptococcus dysgalactiae 0.003
 Strep. dysgalactiae negative (n = 220) 0
 + (n = 14) −0.966 −1.882; −0.049 0.039
 ++/+++ (n = 19) 1.100 0.274; 1.926 0.009
CNS <0.001
 CNS negative (n = 162) 0
 + (n = 78) −0.908 −1.390; −0.425 0.000
 ++/+++ (n = 13) −1.239 −2.162; −0.316 0.009
Corynebacterium bovis
 C. bovis negative (n = 200) 0
 +/++ (n = 53) −1.323 −1.855; −0.791 0.000
PCR positive (n = 226) 0
PCR negative (n = 27) −0.918 −1.687; −0.149 0.019
Intercept 3.116 2.018; 4.214 0.000
1+ = small quantities of bacterial DNA; ++ = intermediate quantities of bacterial DNA; +++ = large quantities of bacterial DNA.
2Estimates are on a square root scale.
3Number of milk samples not containing DNA from detected bacteria.
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when bacteria are present in small quantities and may 
be undetectable using conventional methods. On the 
other hand, the high sensitivity of the PCR analysis 
and the methods used to collect milk samples can cause 
false-positive results, especially in large herds when 
many staff members are involved in the sampling. 
The presence of microbes in a milk sample does not 
necessarily prove that those microbes caused the IMI. 
Interpretation of PCR results can be challenging and 
needs more guidance, even though PCR-based diagnos-
tics are already in routine use in some countries. In 
the interpretation of PCR results, detection of a single 
species, preferably in moderate or large quantities, or 
detection of one dominating species with some other 
species provides a likely bacteriological diagnosis. The 
final diagnosis of mastitis always requires a full comple-
ment of supporting information, such as knowledge 
of the clinical signs and inflammation in the quarter 
(Pyörälä, 2012).
In the present study, Hp performed better than 
MAA in describing bovine inflammatory response. A 
constant increase in concentrations of Hp in the milk 
along with increasing quantities of DNA (except CNS 
and C. bovis) was observed. Haptoglobin could, thus, 
be a better marker than MAA for indicating the local 
inflammatory response in clinical mastitis caused by 
different pathogens.
CONCLUSIONS
The quantity of bacterial DNA in milk samples was 
associated with concentrations of APP and NAGase 
activity in the milk. These indicators reflect the in-
flammatory reaction in the mammary gland, and their 
concentrations increased with increasing severity of 
mastitis. Concentrations of APP and NAGase activity 
in milk significantly differed between different mastitis-
causing bacterial species. Indicators of inflammation in 
milk, such as APP concentration and NAGase activity, 
may be useful to complete and support the bacterio-
logical diagnosis of mastitis.
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